To schedule an appointment please call or text (510)471-5880

HELP STOP THE SPREAD OF COVID-19! Call or text (510)471-5880 before visiting TVHC if you have a cough, fever, loss of smell, or have been in contact with someone who has been dignosed with COVID-19.

Covid-19 Vaccine

Our waitlist for the Pfizer COVID-19 vaccine is now open to current TVHC patients and community members ages 12 years and up, and the Johnson & Johnson vaccine for those ages 18 years and up. 

Click the button below to schedule your vaccine appointment.

Please note: on April 23rd, 2021 the FDA announced that the pause on the Johnson & Johnson vaccine, Janssen , has been lifted and after thorough additional studies, determined the single-dose safe to use.

Scheduling Your COVID Vaccine

In efforts to protect as many patients and community members as possible against COVID, we have switched from the Moderna vaccine to the Pfizer vaccine, since Pfizer is the only vaccine approved for children ages 12 and up. 

For people who are 18 years and older who prefer the single dose vaccine, we are offering the Johnson & Johnson vaccine which offers full immunity after 2 weeks.

Please click the following link to schedule your COVID vaccine appointment: 

COVID-19 Vaccines


Vaccine Safety

COVID vaccines have gone through rigorous studies to ensure they are safe. Over 44 million people in the U.S. have received the COVID vaccines.

Vaccine Dosage

Both Moderna and Pfizer are mRNA vaccines that require 2 doses. The 2nd dose is given within 3 to 4 weeks after the first dose .

What to Expect

Possible side effects are redness or
swelling at the injection site, fever, body aches and fatigue. Side effects could last 1 to 2 days.

Frequently Asked Questions

Currently there are two vaccines, made by Pfizer and Moderna that received Emergency Use Authorization from the FDA in December 2020.

The technology for these types of vaccines (mRNA vaccines) has been in development for other viruses for over 10 years.  When China shared the genetic information from the COVID-19 virus last spring, researchers immediately started applying it to creating the new vaccine. 

Vaccines usually take much longer to develop, mostly because vaccines are not a big money-maker for pharmaceutical companies, and there is no guaranteed market.  In this case, the pharmaceutical companies were aided by infusions of money upfront, and knew that they had millions of people waiting for a vaccine. 

Vaccines undergo four phases of trials to be approved by the FDA.  The testing did NOT skip any steps for assessing safety.  Social media and the pandemic motivated many people to volunteer for trials.  And since the virus is so widespread, volunteers were exposed to the virus sooner than usually occurs (usually when you are testing a vaccine, researchers have to wait a longer time for the volunteer to be exposed to the virus in order to know if the vaccine works).

The vaccine is completely free of animal tissue – no fetal tissue, no egg particles, no animal cells.

No. It is not possible for the COVID-19 vaccine to cause COVID disease.  There are no viral particles in the vaccine. 

You may have some side effects, which are normal signs that your body is building protection. These side effects may affect your ability to do daily activities, but they should go away in a few days. Most of the time they are very minor, like pain at the injection site, muscle aches, fever or headache.  

People with severe allergies should consult their PCPs regarding vaccination.  However, allergies to the ingredients of the vaccine are not common.

Getting COVID-19 might offer some natural protection or immunity from reinfection with the virus that causes COVID-19. But it’s not clear how long this protection lasts. Because reinfection is possible and COVID-19 can cause severe medical complications, it’s recommended that people who have already had COVID-19 get a COVID-19 vaccine. If you’ve had COVID-19, wait until 90 days after your diagnosis to get a COVID-19 vaccine.

Yes, masking and physical distancing will continue to be critical tools in preventing transmission until a large percentage of the population is vaccinated and we have more information about long-term protection.

Translate »